Compare $OSRH vs $XBIO | Chartloom

Compare

$OSRH vs $XBIO

OSR Holdings Inc · Xenetic Biosciences Inc

OSRH

OSR Holdings Inc

XBIO

Xenetic Biosciences Inc

Compare $OSRH vs $XBIO

Comparing OSR Holdings Inc and Xenetic Biosciences Inc

OSRHOSR Holdings Inc

XBIOXenetic Biosciences Inc

OSRHOSR Holdings Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-4.6%

YTD performance

-64.4%

52W performance

-65.3%

FCF yield

-100.0%

XBIOXenetic Biosciences Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

33.3%

YTD performance

-0.9%

52W performance

-79.4%

FCF yield

-47.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OSRH

XBIO

Detailed metrics comparison

OSRH

OSR Holdings Inc

XBIO

Xenetic Biosciences Inc

Market Cap

OSRH$7M

XBIO$5M

Enterprise Value

OSRH$11M

XBIO$-2M

Price

OSRH$0.21

XBIO$2.13

P/E Ratio

OSRHN/A

XBION/A

P/S Ratio

OSRH4.08x

XBIO1.50x

EV/Sales

OSRH6.25x

XBIO-0.49x

EV/EBITDA

OSRH0.00x

XBIO0.00x

P/B Ratio

OSRH0.07x

XBIO0.81x

P/FCF Ratio

OSRHN/A

XBION/A

EV/FCF

OSRH-1.53x

XBIO0.69x

PEG Ratio

OSRHN/A

XBION/A

Forward P/E (NTM)

OSRHN/A

XBION/A

Forward P/S (NTM)

OSRHN/A

XBION/A

Revenue (TTM)

OSRH$2M

XBIO$3M

Revenue Growth (YoY)

OSRH-4.6%

XBIO33.3%

Forward Rev Growth

OSRH0.0%

XBIO-16.7%

Gross Margin (TTM)

OSRH35.3%

XBIO98.7%

Operating Margin (TTM)

OSRH0.0%

XBIO0.0%

EBITDA Margin (TTM)

OSRH-410.1%

XBIO-81.0%

Net Margin (TTM)

OSRH-593.2%

XBIO-75.9%

FCF Margin (TTM)

OSRH-407.9%

XBIO-70.9%

Net Income (TTM)

OSRH$-11M

XBIO$-2M

FCF (TTM)

OSRH$-7M

XBIO$-2M

EPS (TTM)

OSRH-$0.25

XBIO-$1.08

ROE (TTM)

OSRH-1167.0%

XBIO-4062.0%

ROA (TTM)

OSRH-624.0%

XBIO-3497.0%

ROIC (TTM)

OSRH-1110.0%

XBIO-4062.0%

Cash

OSRH$1M

XBIO$6M

Debt

OSRH$5M

XBIO$0

Net Cash/Debt

OSRH$-4M

XBIO$6M

Current Ratio (TTM)

OSRH0.18x

XBIO7.43x

Quick Ratio (TTM)

OSRH0.14x

XBIO7.23x

Debt/Equity (TTM)

OSRH0.05x

XBIO0.00x

Debt/Assets (TTM)

OSRH0.0%

XBIO0.0%

Interest Coverage (TTM)

OSRHN/A

XBION/A

Net Debt/EBITDA (TTM)

OSRH0.00x

XBIO0.00x

Beta

OSRH0.51

XBIO2.36

52W Performance

OSRH-65.3%

XBIO-79.4%

YTD Performance

OSRH-64.4%

XBIO-0.9%

% from 52W High

OSRH-76.9%

XBIO-79.2%

% from 52W Low

OSRH180.0%

XBIO13.9%

Asset Turnover (TTM)

OSRH0.01x

XBIO0.46x

FCF Yield (TTM)

OSRH-100.0%

XBIO-47.4%

Earnings Yield (TTM)

OSRH-145.5%

XBIO-50.7%

Dividend Yield (TTM)

OSRHN/A

XBION/A

Rule of 40

OSRH-412.5

XBIO-37.6

EV/GP/RG

OSRHN/A

XBION/A

Ticker research

View OSRH research View XBIO research

Metric	OSRH OSR Holdings Inc	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$7M	$5M
Enterprise Value	$11M	$-2M
Price	$0.21	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	4.08x	1.50x
EV/Sales	6.25x	-0.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.07x	0.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$2M	$3M
Revenue Growth (YoY)	-4.6%	33.3%
Forward Rev Growth	0.0%	-16.7%
Profitability
Gross Margin (TTM)	35.3%	98.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-410.1%	-81.0%
Net Margin (TTM)	-593.2%	-75.9%
FCF Margin (TTM)	-407.9%	-70.9%
Net Income (TTM)	$-11M	$-2M
FCF (TTM)	$-7M	$-2M
EPS (TTM)	-$0.25	-$1.08
ROE (TTM)	-1167.0%	-4062.0%
ROA (TTM)	-624.0%	-3497.0%
ROIC (TTM)	-1110.0%	-4062.0%
Financial Health
Cash	$1M	$6M
Debt	$5M	$0
Net Cash/Debt	$-4M	$6M
Current Ratio (TTM)	0.18x	7.43x
Quick Ratio (TTM)	0.14x	7.23x
Debt/Equity (TTM)	0.05x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.51	2.36
52W Performance	-65.3%	-79.4%
YTD Performance	-64.4%	-0.9%
% from 52W High	-76.9%	-79.2%
% from 52W Low	180.0%	13.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.46x
FCF Yield (TTM)	-100.0%	-47.4%
Earnings Yield (TTM)	-145.5%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-412.5	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View OSRH research	View XBIO research

Valuation

P/S Ratio

XBIO

1.50x

OSRH

4.08x

EV/FCF

OSRH

-1.53x

XBIO

0.69x

Growth & revenue

Revenue Growth TTM

XBIO

33.3%

OSRH

-4.6%

Forward Revenue Growth

OSRH

0.0%

XBIO

-16.7%

Profitability & performance

Gross Margin

XBIO

98.7%

OSRH

35.3%

ROE

OSRH

-1167.0%

XBIO

-4062.0%

FCF Yield %

XBIO

-47.4%

OSRH

-100.0%

52-Week Performance

OSRH

-65.3%

XBIO

-79.4%

Detailed metrics comparison

OSRH

OSR Holdings Inc

XBIO

Xenetic Biosciences Inc

Market Cap

OSRH$7M

XBIO$5M

Enterprise Value

OSRH$11M

XBIO$-2M

Price

OSRH$0.21

XBIO$2.13

P/E Ratio

OSRHN/A

XBION/A

P/S Ratio

OSRH4.08x

XBIO1.50x

EV/Sales

OSRH6.25x

XBIO-0.49x

EV/EBITDA

OSRH0.00x

XBIO0.00x

P/B Ratio

OSRH0.07x

XBIO0.81x

P/FCF Ratio

OSRHN/A

XBION/A

EV/FCF

OSRH-1.53x

XBIO0.69x

PEG Ratio

OSRHN/A

XBION/A

Forward P/E (NTM)

OSRHN/A

XBION/A

Forward P/S (NTM)

OSRHN/A

XBION/A

Revenue (TTM)

OSRH$2M

XBIO$3M

Revenue Growth (YoY)

OSRH-4.6%

XBIO33.3%

Forward Rev Growth

OSRH0.0%

XBIO-16.7%

Gross Margin (TTM)

OSRH35.3%

XBIO98.7%

Operating Margin (TTM)

OSRH0.0%

XBIO0.0%

EBITDA Margin (TTM)

OSRH-410.1%

XBIO-81.0%

Net Margin (TTM)

OSRH-593.2%

XBIO-75.9%

FCF Margin (TTM)

OSRH-407.9%

XBIO-70.9%

Net Income (TTM)

OSRH$-11M

XBIO$-2M

FCF (TTM)

OSRH$-7M

XBIO$-2M

EPS (TTM)

OSRH-$0.25

XBIO-$1.08

ROE (TTM)

OSRH-1167.0%

XBIO-4062.0%

ROA (TTM)

OSRH-624.0%

XBIO-3497.0%

ROIC (TTM)

OSRH-1110.0%

XBIO-4062.0%

Cash

OSRH$1M

XBIO$6M

Debt

OSRH$5M

XBIO$0

Net Cash/Debt

OSRH$-4M

XBIO$6M

Current Ratio (TTM)

OSRH0.18x

XBIO7.43x

Quick Ratio (TTM)

OSRH0.14x

XBIO7.23x

Debt/Equity (TTM)

OSRH0.05x

XBIO0.00x

Debt/Assets (TTM)

OSRH0.0%

XBIO0.0%

Interest Coverage (TTM)

OSRHN/A

XBION/A

Net Debt/EBITDA (TTM)

OSRH0.00x

XBIO0.00x

Beta

OSRH0.51

XBIO2.36

52W Performance

OSRH-65.3%

XBIO-79.4%

YTD Performance

OSRH-64.4%

XBIO-0.9%

% from 52W High

OSRH-76.9%

XBIO-79.2%

% from 52W Low

OSRH180.0%

XBIO13.9%

Asset Turnover (TTM)

OSRH0.01x

XBIO0.46x

FCF Yield (TTM)

OSRH-100.0%

XBIO-47.4%

Earnings Yield (TTM)

OSRH-145.5%

XBIO-50.7%

Dividend Yield (TTM)

OSRHN/A

XBION/A

Rule of 40

OSRH-412.5

XBIO-37.6

EV/GP/RG

OSRHN/A

XBION/A

Ticker research

View OSRH research View XBIO research

Metric	OSRH OSR Holdings Inc	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$7M	$5M
Enterprise Value	$11M	$-2M
Price	$0.21	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	4.08x	1.50x
EV/Sales	6.25x	-0.49x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.07x	0.81x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$2M	$3M
Revenue Growth (YoY)	-4.6%	33.3%
Forward Rev Growth	0.0%	-16.7%
Profitability
Gross Margin (TTM)	35.3%	98.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-410.1%	-81.0%
Net Margin (TTM)	-593.2%	-75.9%
FCF Margin (TTM)	-407.9%	-70.9%
Net Income (TTM)	$-11M	$-2M
FCF (TTM)	$-7M	$-2M
EPS (TTM)	-$0.25	-$1.08
ROE (TTM)	-1167.0%	-4062.0%
ROA (TTM)	-624.0%	-3497.0%
ROIC (TTM)	-1110.0%	-4062.0%
Financial Health
Cash	$1M	$6M
Debt	$5M	$0
Net Cash/Debt	$-4M	$6M
Current Ratio (TTM)	0.18x	7.43x
Quick Ratio (TTM)	0.14x	7.23x
Debt/Equity (TTM)	0.05x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.51	2.36
52W Performance	-65.3%	-79.4%
YTD Performance	-64.4%	-0.9%
% from 52W High	-76.9%	-79.2%
% from 52W Low	180.0%	13.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.46x
FCF Yield (TTM)	-100.0%	-47.4%
Earnings Yield (TTM)	-145.5%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-412.5	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View OSRH research	View XBIO research